4.6 Article

Intuitive repositioning of an anti-depressant drug in combination with tivozanib: precision medicine for breast cancer therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy

Masoom Raza et al.

Summary: Precision medicine has revolutionized cancer therapy by targeting unique biomarkers in different types of cancers, leading to more efficient treatment. Despite challenges posed by tumor heterogeneity, the development of precision medicine allows for the discovery and utilization of various gene mutations to design more targeted therapies. It also helps in identifying potential cross-cancer therapeutic benefits based on similarities in signaling pathways and machinery.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Review Cell Biology

Insights into exchange factor directly activated by cAMP (EPAC) as potential target for cancer treatment

Naveen Kumar et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)

Article Oncology

Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma

Jayashree Kalpathy-Cramer et al.

JOURNAL OF NEURO-ONCOLOGY (2017)

Article Oncology

MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer

Madeleine J. Oudin et al.

MOLECULAR CANCER THERAPEUTICS (2017)

Review Oncology

Drug repurposing for the treatment of glioblastoma multiforme

Claudia Abbruzzese et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Cell Biology

Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis

Naveen Kumar et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2017)

Article Pharmacology & Pharmacy

Tivozanib: First Global Approval

Esther S. Kim

Review Medicine, Research & Experimental

Pharmacological approach for drug repositioning against cardiorenal diseases

Yoshito Zamami et al.

JOURNAL OF MEDICAL INVESTIGATION (2017)

Article Biochemistry & Molecular Biology

AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4

Zhi-Yan Hu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Multidisciplinary Sciences

Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization

Keiichiro Hayashi et al.

SCIENTIFIC REPORTS (2016)

Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Oncology

βIII-Tubulin Regulates Breast Cancer Metastases to the Brain

Deepak Kanojia et al.

MOLECULAR CANCER THERAPEUTICS (2015)

Review Biochemistry & Molecular Biology

Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs

Joong Sup Shim et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)

Article Surgery

Breast-Conserving Therapy for Triple-Negative Breast Cancer

Alexandra Gangi et al.

JAMA SURGERY (2014)

Article Oncology

Development of Therapeutic Combinations Targeting Major Cancer Signaling Pathways

Timothy A. Yap et al.

JOURNAL OF CLINICAL ONCOLOGY (2013)

Editorial Material Pharmacology & Pharmacy

Tivozanib: current status and future directions in the treatment of solid tumors

Sumanta K. Pal et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)

Article Medicine, Research & Experimental

Loss of occludin leads to the progression of human breast cancer

Tracey A. Martin et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)

Article Psychology, Developmental

Pilot study: Fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer

D Gothelf et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2005)

Review Medicine, General & Internal

Breast and ovarian cancer

R Wooster et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)